The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells

Kaulfuss, M; Mietz, J; Fabri, A; vom Berg, J; Munz, C; Chijioke, O

Chijioke, O (通讯作者)，Univ Zurich, Inst Expt Immunol, Cellular Immunotherapy, Zurich, Switzerland.;Chijioke, O (通讯作者)，Univ Hosp Basel, Inst Med Genet & Pathol, Basel, Switzerland.

SCIENTIFIC REPORTS, 2023; 13 (1):

Abstract

Human natural killer (NK) cells are cytotoxic effector cells that are increasingly harnessed in cancer immunotherapy. NKG2A/CD94 is an inhibitory rece......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索